A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
It ends a political standoff that briefly saw Yahya Jammeh and Adama Barrow claiming leadership of this tiny West African nation.
Britain is braced for sub-zero temperatures expected to bring 'harsh frost' through next week.
The historic moment was watched by 500 people in the Church in Wales who cheered after the ceremony.